Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden Anstalt des öffentlichen Rechts des Freistaates Sachsen
Universitätsklinikum Carl Gustav Carus
ZKN Logo
  • The Center
    • Multiple Sclerosis Center Dresden
      • Patient Information
      • Contact MSC
      • Physicians & Nurses
      • Study Team
      • Neuropsychology
    • Mobility Center
      • The Mobility Center
      • Walking Assessment
      • Jump Assessment
      • DIERS
      • EMIQ
      • Projects
    • Neuroimmunological Laboratory
      • The NIL
      • Neurofilament light chain
    • Autonomic & Neuroendocrinological Functional Laboratory
      • The ANF
      • ANF Assessment
    • MS Living Lab
    • Management & Science
      • Team Management & Science
      • Projects
      • eHealth & Analytics
        • MSDS 3D
        • MSDS Clinic & Practice
        • MS-HRS
        • MTRS
      • Multiple Sclerosis Management
  • Aktuelles
    • Neuigkeiten
    • Publikationen
    • Veranstaltungen
      • Adventssymposium
      • MS Tag 2025
      • Multiple Sklerose 360°
      • Welt-MS-Tag 2021
    • Doktorarbeiten
    • Jobs
    • Kontakt
    • Spenden
  • Podcasts & Newsletter
    • Newsletter
    • Patienten-Podcast
    • Ärzte-Podcast
    • Neurovision
    • Digital calender 2026
    • Sherlock-MS-Blog
  • Studien
    • Interventionelle Studien
    • B-SHUTTLE
    • Nicht-interventionelle Studien
    • MS PATHS
    • Konectom
    • Sprachanalyse
MS 360 Grad
EnglishEnglish
DeutschDeutsch
EnglishEnglish

Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" Multiple Sclerosis and Related Disorders 2017

NIL

Jahr

Publikationsjahr
2018

Autoren

Autorenliste der Publikation
Akgün K, Kaufmann M, Ziemssen T.

Verlag

Publisher-Information
Mult Scler Relat Disord 2018;22:68-69.

Link

Zur Publikation (externer Server)
https://doi.org/10.1016/j.msard.2018.03.012

Tags

Forschungsthemen
Multiple SkleroseMS BehandlungNeuroimmunologie
TreatmentsNIL2018

  • Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis

    MS Treatments
    Jahr
    2026

  • Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries

    MS Treatments
    Jahr
    2026

  • Nutritional state-dependent changes in subcortical limbic structures in anorexia nervosa are linked to leptin, ghrelin, and neurofilament light

    Other
    Jahr
    2026

  • Beyond the interferon score: neurofilament light chain and glial fibrillary acidic protein capture immune-mediated neuroinjury and response to JAK inhibition in Aicardi–Goutières syndrome

    NIL
    Jahr
    2026

  • Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy

    Multiple Sclerosis
    Jahr
    2026
  • Start
  • Aktuelles
  • Publikationen
  • NIL
  • Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" Multiple Sclerosis and Related Disorders 2017
Uniklinikum Carl Gustav Carus
UKD Neurologie
TU Dresden
Impressum & Datenschutz
MSZ @ Facebook
MSZ @ Google
ZKN @ Youtube

© 2026
Universitätsklinikum C.G. Carus Dresden an der Technischen Universität Dresden